pSivida Announces UK's NICE Recommends ILUVIEN for Chronic Diabetic Macular Edema in Pseudophakic Eyes
September 30, 2013 at 21:20 PM EDT
pSivida Corp. (NASDAQ: PSDV ) today announced that the United Kingdom's National Institute for Health and Care Excellence (NICE) issued final draft guidance recommending ILUVIEN as an option for the
